The results of the recent survey indicate that more than 3/4 of respondents routinely give a P2Y12 inhibitor before primary percutaneous coronary intervention (PCI). A small minority, only 10%, indicated that they almost never preload prior to primary PCI.

These results are concordant with current ST-segment elevation myocardial infarction (STEMI) guidelines. The 2013 American College of Cardiology and American Heart Association STEMI guidelines give a Class 1 indication that a P2Y12 in degree inhibitor should be given as early as possible or at the time of the procedure in patients undergoing primary PCI.¹ The 2017 European Society of Cardiology STEMI guidelines recommend that the P2Y12 inhibitor be given before, or, at latest, at the time of, PCI.²

References

1. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425.
2. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018;39:119-177.

Keywords: Acute Coronary Syndrome, Myocardial Infarction, American Heart Association, Percutaneous Coronary Intervention, Anterior Wall Myocardial Infarction

< Back to Listings